Dr. Andreadou, PhD, is a Professor of Pharmacology in School of Pharmacy, NKUA and has a long term experience in cardiac toxicity, and cardiac pharmacology in animal models. She is an expert in molecular signaling of the pathophysiology of the heart and the required molecular techniques and can provide excellent guidance for the proposal.

Dr. Kastritis, MD PhD, is a Professor of School of Medicine NKUA, and he is already accredited as an expert in the field of amyloidosis and his group has published numerous publications on the management of AL amyloidosis. His clinical expertise will provide the translational insight, the patient samples and required clinical data for this proposal.

Dr. Papanikolaou, MD, is an expert histopathologist in recognising plasma cell dyscrasias and amyloidosis histology features in human samples and has collaborated with the Department of Clinical Therapeutics in the clinical practice and research projects. Her participation is of utmost importance for the histological evaluation of the proposed animal model.

Dr. Davos, MD, PhD, is a cardiologist and Senior researcher in the Cardiovascular Research Laboratory, BRFFA. His contribution to the evaluation of echocardiographic data and characterization of the cardiac phenotype of the proposed model is highly significant.

Dr. Ribeout is a molecular neurobiologist with an extensive background in applying molecular tools to the study of disease pathogenesis in cellular and in vivo models, including expression and purification of recombinant (cell-produced) proteins, and the application of viral expression approaches. Dr. Rideout’s background and experience is very well suited to help achieve the goals of this project, particularly within the tasks requiring the expression and purification of proteins from mammalian cells.
Dr. Nikolaou, is a Post Doctoral research fellow who has accelerated the establishment of in vivo and in vitro models of light chain associated cardiotoxicity. She is Felasa accredited and has experience in in vivo experimental protocols, so her contribution throughout the project will be valuable.

Dr. Varela, PhD is an expert technician in performing echocardiography evaluation in laboratory animals. She is a highly valuable member of the research team due to her experience, important research work and professionalism.